Ponoi II Management, LLC, 10% Owner at RAPT Therapeutics, Inc. (RAPT), sold 1,238,776 shares at $35.19 ($2.5M) on 2021-09-10, disclosed to the SEC on 2021-09-14.
Open-market sale of $2.5M RAPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,166,666 | $0 | 0.0% |
| 2 | $35.19 | 7,187 | $253K | 10.0% |
| 3 | $35.19 | 7,187 | $253K | 10.0% |
| 4 | $35.19 | 7,231 | $254K | 10.0% |
| 5 | $35.19 | 7,231 | $254K | 10.0% |
| 6 | $35.19 | 7,320 |
| $258K |
| 10.1% |
| 7 | $35.19 | 7,320 | $258K | 10.1% |
| 8 | $35.25 | 4,803 | $169K | 6.7% |
| 9 | $35.25 | 4,803 | $169K | 6.7% |
| 10 | $35.27 | 4,726 | $167K | 6.6% |
| 11 | $35.27 | 4,726 | $167K | 6.6% |
| 12 | $35.28 | 4,788 | $169K | 6.7% |
| 13 | $35.28 | 4,788 | $169K | 6.7% |
| Total | $2.05 avg | 1,238,776 | $2.5M | 100% |
| Filing → |
| CNST | SELL | 2021-02-19 | $370K | — | Filing → |
| RAPT | SELL | 2020-09-23 | $18.8M | — | Filing → |
| NGM | BUY | 2019-10-11 | $924K | — | Filing → |